Comparing two similar injectable medicines in healthy men
This study tests two similar medicines, HLX29 and HLX11, in healthy men to see how the body absorbs and clears them and whether they are safe. Participation helps find out if one medicine can replace the other.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 to 55 years.
- You are generally healthy with no major medical conditions.
- Your body mass index (BMI) is between 18 and 30.
- You have not taken any medicines (including over-the-counter or herbal) in the past 28 days.
- You have not donated blood in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new version of a medication used for breast cancer. Because healthy people are needed first, it checks how the body processes the new drug and whether it causes side effects, helping to ensure it is safe before patients use it.
This study tests a new medicine called BLX-7006 in healthy adults to see if it is safe and to learn how the body handles it. Participating could help decide if the drug should be tested in people with certain conditions later.
This trial compares two different forms of a medication to see how they are absorbed and processed by the body and to check that they are safe. It is an early-stage study in healthy volunteers.
This study tests a new investigational drug called BLX-0871 in healthy adults to see how safe it is and how the body processes it. Participation may help determine the right dose for future studies, but it will not treat any existing condition.
This early-phase study tests an experimental drug called HXN6005 in healthy adults to see how safe it is and how the body handles it. It's looking for volunteers who are generally healthy and meet basic age and weight requirements.
This trial is testing a new study drug called XKH001 in healthy volunteers to see how it affects the body. It is the first time this drug is being studied in people of European descent.
Hear when a new Health Adult Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.